Login
Barrier Express Certificate
Symbol:
AFOBIL
ISIN:
CH0585067827
Issuer:
Banque Int. à Luxembourg
SIX Structured Products trading
| SIX Structured Products | Bid | Ask | Notation | |
|---|---|---|---|---|
| Please note that data is only available after start of trading. | ||||
Performance
| Closing prev. day | 93.03 | ||||
| Diff. absolute / % | 0.00 | 0.00% | |||
Determined prices
| Last Price | 92.78 | Volume | 50,000 | |
| Time | 11:35:02 | Date | 06/09/2024 |
More Product Information
| Details | Underlying | Payment profile | Risk Indicator | Information & Tools | Similar Products |
Core Data
| Name | Barrier Express Certificate |
| ISIN | CH0585067827 |
| Valor | 58506782 |
| Symbol | AFOBIL |
| Type | Express Certificates |
| SVSP Code | 1260 |
| Barrier reached | No |
| COSI Product | No |
| Exercise type | European |
| Currency | Euro |
| First Trading Date | 20/07/2021 |
| Date of maturity | 20/07/2027 |
| Last trading day | 29/06/2027 |
| Settlement Type | Cash payout |
| IRS 871m | Not applicable |
| Currency safeguarded | Yes |
| Pricing | Dirty |
| Issuer | Banque Int. à Luxembourg |
market maker quality Date: 20/11/2024
| Average Spread | - |
| Last Best Bid Price | 79.52 % |
| Last Best Ask Price | - % |
| Last Best Bid Volume | 250,000 |
| Last Best Ask Volume | 0 |
| Average Buy Volume | 0 |
| Average Sell Volume | 0 |
| Average Buy Value | 0 EUR |
| Average Sell Value | 0 EUR |
| Spreads Availability Ratio | 0.00% |
| Quote Availability | 99.93% |
Underlyings
| Name | Roche AG | Bouygues S.A. |
| ISIN | CH0012032048 | FR0000120503 |
| Price | 254.30 CHF |
28.90 EUR
|
| Date | 22/11/24 17:30 | 22/11/24 22:04 |
| Cap | 348.80 CHF | 31.32 EUR |
| Distance to Cap | -94.3 | -2.67 |
| Distance to Cap in % | -37.05% | -9.32% |
| Is Cap Level reached | No | No |
| Barrier | 209.28 CHF | 18.792 EUR |
| Distance to Barrier | 45.22 | 9.858 |
| Distance to Barrier in % | 17.77% | 34.41% |
| Is Barrier reached | No | No |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)